Nature structural & molecular biology, 2018-11, Vol.25 (11), p.1047-1058
2018
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- DNA damage-induced cell death relies on SLFN11-dependent cleavage of distinct type II tRNAs
- Ist Teil von
- Nature structural & molecular biology, 2018-11, Vol.25 (11), p.1047-1058
- Ort / Verlag
- United States
- Erscheinungsjahr
- 2018
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Transcriptome analysis reveals a strong positive correlation between human Schlafen family member 11 (SLFN11) expression and the sensitivity of tumor cells to DNA-damaging agents (DDAs). Here, we show that SLFN11 preferentially inhibits translation of the serine/threonine kinases ATR and ATM upon DDA treatment based on distinct codon usage without disrupting early DNA damage response signaling. Type II transfer RNAs (tRNAs), which include all serine and leucine tRNAs, are cleaved in a SLFN11-dependent manner in response to DDAs. Messenger RNAs encoded by genes with high TTA (Leu) codon usage, such as ATR, display utmost susceptibility to translational suppression by SLFN11. Specific attenuation of tRNA-Leu-TAA sufficed to ablate ATR protein expression and restore the DDA sensitivity of SLFN11-deficient cells. Our study uncovered a novel mechanism of codon-specific translational inhibition via SLFN11-dependent tRNA cleavage in the DNA damage response and supports the notion that SLFN11-deficient tumor cells can be resensitized to DDAs by targeting ATR or tRNA-Leu-TAA.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1545-9993eISSN: 1545-9985DOI: 10.1038/s41594-018-0142-5Titel-ID: cdi_pubmed_primary_30374083
- Format
- –
- Schlagworte
- Ataxia Telangiectasia Mutated Proteins - biosynthesis, Ataxia Telangiectasia Mutated Proteins - genetics, Camptothecin - pharmacology, Cell Death - drug effects, Cell Death - genetics, Cell Death - physiology, Cell Line, Tumor, Codon - genetics, DNA Damage, HEK293 Cells, Humans, Nuclear Proteins - antagonists & inhibitors, Nuclear Proteins - genetics, Nuclear Proteins - metabolism, Protein Biosynthesis - drug effects, RNA, Small Interfering - genetics, RNA, Transfer - classification, RNA, Transfer - genetics, RNA, Transfer - metabolism, RNA, Transfer, Leu - genetics, RNA, Transfer, Leu - metabolism, Topoisomerase I Inhibitors - pharmacology